Bo Yao

Beijing, 100071, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Efficacy and Prognostic Factors of Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia

Efficacy and Prognostic Factors of Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia

Journal: Zhongguo shi yan xue ye xue za zhi

Published: December 09, 2023

Mismatched donor cell infusion-related syndrome following microtransplant in patients with acute myeloid leukemia.

Mismatched donor cell infusion-related syndrome following microtransplant in patients with acute myeloid leukemia.

Journal: Chinese medical journal

Published: April 07, 2023

Immunophenotypic Features and Clinical Prognosis of Patients with Mixed Phenotype Acute Leukemia

Immunophenotypic Features and Clinical Prognosis of Patients with Mixed Phenotype Acute Leukemia

Journal: Zhongguo shi yan xue ye xue za zhi

Published: October 08, 2022

Hyper-CVAD-Based Stem Cell Microtransplant as Post-Remission Therapy in Acute Lymphoblastic Leukemia.

Hyper-CVAD-Based Stem Cell Microtransplant as Post-Remission Therapy in Acute Lymphoblastic Leukemia.

Journal: Stem cells translational medicine

Published: April 26, 2022

Comparison of microtransplantation, chemotherapy and allogeneic transplantation in post-remission therapy for Philadelphia chromosome-positive acute lymphoblastic leukemia.

Comparison of microtransplantation, chemotherapy and allogeneic transplantation in post-remission therapy for Philadelphia chromosome-positive acute lymphoblastic leukemia.

Journal: American journal of cancer research

Published: August 09, 2020

HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia: Results From the Microtransplantation Interest Group.

HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia: Results From the Microtransplantation Interest Group.

Journal: JAMA oncology

Published: September 15, 2017

Significance of Monitoring Minimal Residual Disease by Flow Cytometry in Acute Leukemia Patients Underwent Nonmyeloablative Allo-HSCT

Significance of Monitoring Minimal Residual Disease by Flow Cytometry in Acute Leukemia Patients Underwent Nonmyeloablative Allo-HSCT

Journal: Zhongguo shi yan xue ye xue za zhi

Published: June 24, 2017

Features of Immunophenotypes and Characteristics of Molecular Biology and Cellular Genetics of AML Patients with CD4 and CD7 Expression

Features of Immunophenotypes and Characteristics of Molecular Biology and Cellular Genetics of AML Patients with CD4 and CD7 Expression

Journal: Zhongguo shi yan xue ye xue za zhi

Published: December 28, 2016

Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia.

Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia.

Journal: Journal of hematology & oncology

Published: September 10, 2016

Characteristics and Prognosis of 24 Cases of Primary Acute Myeloid Leukemia with Trisomy 8

Characteristics and Prognosis of 24 Cases of Primary Acute Myeloid Leukemia with Trisomy 8

Journal: Zhongguo shi yan xue ye xue za zhi

Published: June 26, 2016

Clinical efficacy of switching to 2nd generation of tyrosine kinase inhibitor on CML patients at poor responses to imatinib

Clinical efficacy of switching to 2nd generation of tyrosine kinase inhibitor on CML patients at poor responses to imatinib

Journal: Zhongguo shi yan xue ye xue za zhi

Published: February 18, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026